Casdin Capital’s Kronos Bio KRON Stock Holding History

Casdin Capital’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-123,839	Closed	-$102K	–	37
2025 Q1	$102K	Hold	123,839	–	–	0.01%	44
2024 Q4	$118K	Hold	123,839	–	–	0.01%	39
2024 Q3	$124K	Hold	123,839	–	–	0.01%	35
2024 Q2	$154K	Hold	123,839	–	–	0.01%	38
2024 Q1	$161K	Hold	123,839	–	–	0.01%	37
2023 Q4	$155K	Hold	123,839	–	–	0.02%	38
2023 Q3	$161K	Hold	123,839	–	–	0.02%	40
2023 Q2	$213K	Hold	123,839	–	–	0.02%	40
2023 Q1	$181K	Hold	123,839	–	–	0.01%	41
2022 Q4	$201K	Hold	123,839	–	–	0.02%	46
2022 Q3	$415K	Hold	123,839	–	–	0.03%	36
2022 Q2	$451K	Sell	123,839 -459,597	-79%	-$2.08M	0.04%	39
2022 Q1	$4.22M	Hold	583,436	–	–	0.19%	43
2021 Q4	$7.93M	Hold	583,436	–	–	0.22%	48
2021 Q3	$12.2M	Hold	583,436	–	–	0.3%	44
2021 Q2	$14M	Hold	583,436	–	–	0.35%	40
2021 Q1	$17.1M	Hold	583,436	–	–	0.51%	34
2020 Q4	$17.4M	Buy	+583,436	New	+$18.3M	0.52%	37

Casdin Capital's KRON Position: Q2 2025 in Review

Casdin Capital sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 123,839 shares — an estimated $102K sold.

Casdin Capital first reported a position in KRON in Q4 2020 and held it in 18 quarters. The position peaked at $17.4M in Q4 2020. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

Casdin Capital reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
Casdin Capital sold 123,839 Kronos Bio shares in Q2 2025, an estimated $102K.
Casdin Capital first reported a position in Kronos Bio in Q4 2020 and held it in 18 quarters.
Casdin Capital's Kronos Bio position peaked at $17.4M in Q4 2020.
0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on Casdin Capital's 13F filing for Q2 2025, filed 14 Aug 2025.